MetaCap

Kardigan Insider Trades

NASDAQ: KARDHealth CareBiotechnology: Pharmaceutical PreparationsUSD

11.54-0.98 (-7.83%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
3 · $90.00M
Sales
0 · $0
Shares bought / sold
5.63M / 0
Net activity
Net buying $90.0 million

Kardigan insider activity

Over the last 12 months, Kardigan insiders reported 23 transactions on SEC Form 4: 3 open-market purchases and 0 sales. Insiders bought $90.0 million and sold $0 worth of stock, for net insider buying of $90.0 million. The most recent filing shows HRTG GPE, LLC & HRTG PV, L.P. & HRTG CIF 2024, L.P. & Kelly Kevin Anthony & Johnson Keith Bryon (10% Owner) buying 3,125,000 shares at $16.00 on Jun 22, 2026.

Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put KARD's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

KARD insider transactions

Kardigan insider transactions
DateInsiderTypeSharesValueFiling
Jun 22, 2026ARCH Venture Partners XIII, LLC & ARCH Venture Partners XIII, L.P. & ARCH Venture Fund XIII, L.P. & CRANDELL KEITH & NELSEN ROBERT & Burow Kristina & GILLIS STEVENDirectorBuy1,250,000$20.00MForm 4
Jun 22, 2026BERNS PAUL LDirectorBuy1,250,000$20.00MForm 4
Jun 22, 2026HRTG GPE, LLC & HRTG PV, L.P. & HRTG CIF 2024, L.P. & Kelly Kevin Anthony & Johnson Keith Bryon10% OwnerBuy3,125,000$50.00MForm 4
Jun 17, 2026Edelberg JayChief Medical OfficerAward47,784—Form 4
Jun 17, 2026Edelberg JayChief Medical OfficerConversion97,587—Form 4
Jun 17, 2026Giordano Douglas E.DirectorAward20,706—Form 4
Jun 17, 2026GIANAKAKOS ANASTASIOSPresident & CEOConversion498,692—Form 4
Jun 17, 2026GIANAKAKOS ANASTASIOSPresident & CEOConversion41,001—Form 4
Jun 17, 2026GIANAKAKOS ANASTASIOSPresident & CEOConversion28,702—Form 4
Jun 17, 2026Walbert Timothy PDirectorAward20,706—Form 4
Jun 17, 2026Moriarty John BChief Legal OfficerAward47,784—Form 4
Jun 17, 2026BERNS PAUL LDirectorAward20,706—Form 4
Jun 17, 2026BERNS PAUL LDirectorConversion13,792,035—Form 4
Jun 17, 2026ARCH Venture Partners XIII, LLC & ARCH Venture Partners XIII, L.P. & ARCH Venture Fund XIII, L.P. & CRANDELL KEITH & NELSEN ROBERT & Burow Kristina & GILLIS STEVENDirectorConversion13,792,035—Form 4
Jun 17, 2026Popovits Kimberly JDirectorAward20,706—Form 4
Jun 17, 2026Jahn BrianneChief Financial OfficerAward79,640—Form 4
Jun 17, 2026HRTG GPE, LLC & HRTG PV, L.P. & SCHF CIF 2024, L.P. & Kelly Kevin Anthony & Johnson Keith Bryon10% OwnerConversion2,348,373—Form 4
Jun 17, 2026HRTG GPE, LLC & HRTG PV, L.P. & SCHF CIF 2024, L.P. & Kelly Kevin Anthony & Johnson Keith Bryon10% OwnerConversion3,242,993—Form 4
Jun 17, 2026HRTG GPE, LLC & HRTG PV, L.P. & SCHF CIF 2024, L.P. & Kelly Kevin Anthony & Johnson Keith Bryon10% OwnerConversion6,150,502—Form 4
Jun 17, 2026HRTG GPE, LLC & HRTG PV, L.P. & SCHF CIF 2024, L.P. & Kelly Kevin Anthony & Johnson Keith Bryon10% OwnerConversion2,050,166—Form 4
Jun 17, 2026Meeker David PDirectorAward20,706—Form 4
Jun 17, 2026Pasternak AndyChief Strategy OfficerAward79,640—Form 4
Jun 17, 2026PERCEPTIVE ADVISORS LLC & PERCEPTIVE LIFE SCIENCES MASTER FUND LTD & Perceptive Capital Solutions Holdings LP & EDELMAN JOSEPHDirectorAward20,706—Form 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related